Talquetamab Antibody
Talquetamab is a bispecific antibody targeting GPRC5D and CD3, designed for the treatment of multiple myeloma. It redirects T-cells to eliminate GPRC5D-expressing myeloma cells, demonstrating cytotoxic activity in both in vitro assays and in vivo preclinical models.
Product Specifications
Product Name Alternative
DopamineReceptor, Dopamine Receptor, D3, JNJ-7564, JNJ-64407564
Target
Dopamine Receptor, Integrin
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Neuroscience, Pharmacology & Drug Discovery, Signal Transduction
Concentration
4.49 mg/mL
Purity
98.60% (May vary between batches)
Molecular Weight
144.59 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1031480-01 0.05 mg (E-Coli)
Recombinant Rana palustris Brevinin-1PLc
Sign In for Pricing
View Details MBS1031480-02 0.2 mg (E-Coli)
Recombinant Rana palustris Brevinin-1PLc
Sign In for Pricing
View Details MBS1031480-03 0.05 mg (Yeast)
Recombinant Rana palustris Brevinin-1PLc
Sign In for Pricing
View Details MBS1031480-04 0.5 mg (E-Coli)
Recombinant Rana palustris Brevinin-1PLc
Sign In for Pricing
View Details MBS1031480-05 0.05 mg (Baculovirus)
Recombinant Rana palustris Brevinin-1PLc
Sign In for Pricing
View Details MBS1031480-06 0.2 mg (Yeast)
Recombinant Rana palustris Brevinin-1PLc
Sign In for Pricing
View Details